Partner with us

Eigen Bio works with organizations that need to understand the mechanistic biology of disease and treatment response in humans. If the decisions you're making would benefit from a deeper, more rigorous view of how biology behaves in vivo under intervention, we'd like to hear from you.

Pharmaceutical and biotech partners — response biology, patient stratification, biomarker discovery, resistance prediction, indication expansion, and mechanism of action across your pipeline.

Diagnostics partners — co-development of novel diagnostic tests grounded in regulatory biology, built on your proprietary datasets within your secured environment.

Academic and clinical collaborators — translational research programs where mechanistic interpretation of treatment response, disease progression, or patient heterogeneity advances the science.

Patient advocacy organizations and disease foundations — partnerships that bring mechanistic insight to patient communities, inform research priorities, and support evidence-driven care.